BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Packer M. Inferential characterization of the dose-response relationships of neurohormonal antagonists in chronic heart failure: A novel approach based on large-scale trials with active comparators. Int J Cardiol 2018;261:130-3. [PMID: 29548536 DOI: 10.1016/j.ijcard.2018.03.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Tost J, Llorens P, Cotter G, Davison B, Jacob J, Gil V, Herrero P, Martín-Sánchez FJ, Donea R, Rodríguez B, Lucas-Imbernon FJ, Andueza JA, Mecina AB, Torres-Gárate R, Piñera P, Alquézar-Arbé A, Espinosa B, Mebazaa A, Chioncel O, Miró Ò; ICA-SEMES group. Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation. Eur J Intern Med 2021;94:73-84. [PMID: 34446316 DOI: 10.1016/j.ejim.2021.07.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Kobayashi M, Voors AA, Ouwerkerk W, Duarte K, Girerd N, Rossignol P, Metra M, Lang CC, Ng LL, Filippatos G, Dickstein K, van Veldhuisen DJ, Zannad F, Ferreira JP. Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure. Clin Cardiol 2021;44:780-8. [PMID: 33960439 DOI: 10.1002/clc.23576] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Packer M, Metra M. Guideline-directed medical therapy for heart failure does not exist: a non-judgmental framework for describing the level of adherence to evidence-based drug treatments for patients with a reduced ejection fraction. Eur J Heart Fail 2020;22:1759-67. [PMID: 32432391 DOI: 10.1002/ejhf.1857] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
4 Lam PH, Packer M, Fonarow GC, Faselis C, Allman RM, Morgan CJ, Singh SN, Pitt B, Ahmed A. Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial. The American Journal of Medicine 2020;133:e25-31. [DOI: 10.1016/j.amjmed.2019.06.053] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]